Record Date

IGL/SE/2026-27/47 21st August, 2026 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai- 400 051 Scrip Code: 500201 Symbol: INDIAGLYCO Dear Sirs, Sub: Disclosure under Regulations 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)- Intimation of fixation of i.) Effective Date and ii.) Record Date for Allotment of Shares pursuant to Scheme of Arrangement. This is in continuation of our earlier intimation dated 20th August, 2026 bearing no: IGL/SE/2026-27/45, wherein we had informed about the receipt of certified true copy of order of the Hon’ble National Company Law Tribunal, Allahabad Bench, Prayagraj (“NCLT”) sanctioning the Scheme of Arrangement amongst India Glycols Limited (“Demerged Company”/ “the Company”), Ennature Bio Pharma Limited (“Resulting Company 1/EBL”) and IGL Spirits Limited (“Resulting Company 2/IGSL”) and their respective shareholders (“Scheme”), under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (“Act”) read with the rules framed thereunder. We wish to inform you that the Board of Directors of the Company vide their resolution passed by circulation on 21st August, 2026, has fixed: a. Tuesday, 1st September, 2026 as Effective Date of the Scheme, being the date on which the certified true copy of the order of the NCLT sanctioning the Scheme will be filed by the Demerged and each of the Resulting Companies with the Registrar of Companies. b. Wednesday, 2nd September, 2026, as the Record Date in consultation with both the Resulting Company 1 and Resulting Company 2 for the purpose of determining the shareholders of the Company, to whom the shares of Resulting Company 1 and Resulting Company 2 will be allotted in following manner: i. Resulting Company 1 shall issue 1 (One) Equity Share having face value of INR 5 (Indian Rupees Five) each, to the shareholders of Demerged Company holding 3 (Three) Equity Shares of INR 5 (Indian Rupees Five) each. ii. Resulting Company 2 shall issue 1 (One) Equity Share having face value of INR 5 (Indian Rupees Five) each, to the shareholders of Demerged Company holding 1 (One) Equity Share of INR 5 (Indian Rupees Five) each. Further, the equity shares proposed to be allotted by each of the Resulting Companies pursuant to the respective Share Entitlement Ratio set out above, shall, in terms of the Scheme, be listed on the bourses of the National Stock Exchange of India Limited and the BSE Limited subject to the applicable regulations and the necessary regulatory approvals. You are requested to take the above information on record. Thanking you, Yours faithfully, For India Glycols Limited Ankur Jain Head (Legal) & Company Secretary